WO2001078649A3 - Composition medicale pharmaceutique - Google Patents

Composition medicale pharmaceutique Download PDF

Info

Publication number
WO2001078649A3
WO2001078649A3 PCT/RU2001/000154 RU0100154W WO0178649A3 WO 2001078649 A3 WO2001078649 A3 WO 2001078649A3 RU 0100154 W RU0100154 W RU 0100154W WO 0178649 A3 WO0178649 A3 WO 0178649A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracted
pollen
inventive
substances
curing
Prior art date
Application number
PCT/RU2001/000154
Other languages
English (en)
Russian (ru)
Other versions
WO2001078649A2 (fr
Inventor
Alexandr Andreevich Zarubin
Original Assignee
Alexandr Andreevich Zarubin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexandr Andreevich Zarubin filed Critical Alexandr Andreevich Zarubin
Priority to AU2001248943A priority Critical patent/AU2001248943A1/en
Publication of WO2001078649A2 publication Critical patent/WO2001078649A2/fr
Publication of WO2001078649A3 publication Critical patent/WO2001078649A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention relève de la médecine, de la fabrication de compositions médicinales à base de produits naturels ainsi que des industries alimentaire et des concentrés d'aliments. Elle concerne la fabrication de produits médicaux à partir de matières premières naturelles, d'un minéral liquide à poids moléculaire élevé, de résines d'origine végétale, de lipides végétaux et de produits d'apiculture. La composition médicinale peut s'utiliser pour traiter les névroses et l'angioneurose, dans la prévention de la croissance tumorale, dans le traitement intégré de maladies chroniques, après des maladies aiguës thérapeutiques et chirurgicales, lors des états de stress et d'asthénie, en cas de fatigabilité élevée, lors des réactions allergiques et d'athéroscléroses liées au cholestérol. L'invention permet de créer une composition médicinale qui peut s'utiliser en proctologie, urologie, gynécologie, gastro-entérologie, pour la normalisation du fonctionnement des systèmes végétatif, sympathique, parasympathique, endocrinien, pour diminuer les réactions allergiques, augmenter l'activité antitumorale et antimétastasique ainsi que la résistance de l'organisme aux conditions environnementales défavorables et améliorer l'endurance mentale et physique. La composition pharmaceutique comprend des substances médicinales sous forme d'essences de propolis, de Rhodiola rosea et de pollen de fleurs ainsi que des essences dialcoolisées, y compris celles de Leuzea carthamoides, d'Eleutherococcus, de 'mumio', de sève de pins, d'Inula helenium, d'Amaryllis belladonna, de lys blanche ainsi que de la gelée royale, de la poudre de pollen de fleurs et de l'huile de cacao, avec une proportion appropriée des composants. L'invention comprend des exemples avec des ingrédients supplémentaires.
PCT/RU2001/000154 2000-04-17 2001-04-17 Composition medicale pharmaceutique WO2001078649A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001248943A AU2001248943A1 (en) 2000-04-17 2001-04-17 Pharmaceutical curative compound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2000109750/14A RU2174003C1 (ru) 2000-04-17 2000-04-17 Фармацевтическая лечебная композиция, способ лечебного и лечебно-профилактического ее применения
RU2000109750 2000-04-17

Publications (2)

Publication Number Publication Date
WO2001078649A2 WO2001078649A2 (fr) 2001-10-25
WO2001078649A3 true WO2001078649A3 (fr) 2002-03-07

Family

ID=20233529

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2001/000154 WO2001078649A2 (fr) 2000-04-17 2001-04-17 Composition medicale pharmaceutique

Country Status (3)

Country Link
AU (1) AU2001248943A1 (fr)
RU (1) RU2174003C1 (fr)
WO (1) WO2001078649A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202006004962U1 (de) 2006-03-28 2007-08-02 Huber, Klaus, Dr.med. Verwendung von Nisylen, Cepa, Euphrasia, Belladonna und/oder Mercurius solubilis für ein Arzneimittel
RU2324492C1 (ru) * 2006-12-04 2008-05-20 Общество с ограниченной ответственностью "Березовый мир" Средство для профилактики и лечения болезни паркинсона
MD20070085A (ro) * 2007-03-26 2009-02-28 Национальный Фармацевтический Университет Compoziţie farmaceutică pentru tratamentul prostatitei
RU2456012C1 (ru) * 2010-11-08 2012-07-20 Учреждение Российской академии наук Институт мозга человека им. Н.П. Бехтеревой Средство для лечения астенического синдрома у больных рассеянным склерозом
RU2487717C1 (ru) * 2011-12-05 2013-07-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Способ повышения физической работоспособности
RU2521324C1 (ru) * 2013-03-14 2014-06-27 Федеральное Бюджетное Учреждение Науки "Нижегородский Научно-Исследовательский Институт Гигиены И Профпатологии" Федеральной Службы По Надзору В Сфере Защиты Прав Потребителей И Благополучия Человека (Фбун "Нниигп" Роспотребнадзора) Способ коррекции морфофункционального состояния спортсменов
CN103535730A (zh) * 2013-11-01 2014-01-29 王颖 一种红景天精华物质的提取方法
JP6392455B2 (ja) * 2015-05-20 2018-09-19 株式会社山田養蜂場本社 泌尿器症状改善剤

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2033798C1 (ru) * 1993-12-20 1995-04-30 Евгений Иванович Трифонов Средство для апитерапии и апипрофилактики
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
RU2100026C1 (ru) * 1997-02-27 1997-12-27 Чумаян Саида Пайлаковна Средство для местного применения "астхик", обладающее антиинфекционным, антиаллергическим, обезболивающим, рассасывающим, регенерирующим, восстанавливающим и повышающим сопротивляемость организма свойствами
RU2125815C1 (ru) * 1997-07-08 1999-02-10 Удинцев Сергей Николаевич Биологически-активная пищевая добавка "адаптовит"
WO1999052538A1 (fr) * 1998-04-09 1999-10-21 Santillo Humbart D Jr Composition contenant une substance medicinale phytotherapique et un medicament pharmaceutique
RU2142789C1 (ru) * 1997-09-03 1999-12-20 Щербак Игорь Федорович Лекарственное вещество суппозитория с природными продуцентами
RU2146920C1 (ru) * 1998-10-30 2000-03-27 Сараф Александр Сергеевич Комплексный природный препарат в виде суппозиториев для лечения урологических, проктологических и гинекологических заболеваний и способ его получения

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2033798C1 (ru) * 1993-12-20 1995-04-30 Евгений Иванович Трифонов Средство для апитерапии и апипрофилактики
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
RU2100026C1 (ru) * 1997-02-27 1997-12-27 Чумаян Саида Пайлаковна Средство для местного применения "астхик", обладающее антиинфекционным, антиаллергическим, обезболивающим, рассасывающим, регенерирующим, восстанавливающим и повышающим сопротивляемость организма свойствами
RU2125815C1 (ru) * 1997-07-08 1999-02-10 Удинцев Сергей Николаевич Биологически-активная пищевая добавка "адаптовит"
RU2142789C1 (ru) * 1997-09-03 1999-12-20 Щербак Игорь Федорович Лекарственное вещество суппозитория с природными продуцентами
WO1999052538A1 (fr) * 1998-04-09 1999-10-21 Santillo Humbart D Jr Composition contenant une substance medicinale phytotherapique et un medicament pharmaceutique
RU2146920C1 (ru) * 1998-10-30 2000-03-27 Сараф Александр Сергеевич Комплексный природный препарат в виде суппозиториев для лечения урологических, проктологических и гинекологических заболеваний и способ его получения

Also Published As

Publication number Publication date
RU2174003C1 (ru) 2001-09-27
AU2001248943A1 (en) 2001-10-30
WO2001078649A2 (fr) 2001-10-25

Similar Documents

Publication Publication Date Title
WO2003007888A3 (fr) Composes de modulation d'accumulation de graisse
WO1999044581A3 (fr) Composition pharmaceutique de topiramate
CA2290538A1 (fr) Composition comprenant des particules de budesonide cristallines finement divisees
HK1061357A1 (en) Fibrate-statin combinations with reduced fed-fasted effects
PT98890A (pt) Processo para a preparacao de composicoes farmaceuticas antiemeticas contendo uma mistura de ondansetron com um agente antiemetico ou tranquilizante
EP2263667A3 (fr) Compositions comprenant du trans-(+/-)-delta-9-tetrahydrocannabinol cristallin
EP1213026A4 (fr) Agents contenant du ginseng destines a proteger les cellules cerebrales ou les cellules nerveuses
WO2001078649A3 (fr) Composition medicale pharmaceutique
WO1999040883A3 (fr) Compositions et techniques de traitement de la mucoviscidose
WO2005014041A3 (fr) Substances et procedes pour le traitement des amyloses
KR970061244A (ko) 치매 치료용 약학 조성물
BR9809694A (pt) Processo e composição para administração de taxanos oralmente a pacientes humanos
BR0015149A (pt) Método e composições para administração de taxanos oralmente a pacientes humanos
EP1393738A4 (fr) Traitement antidiabetique
CA2521254A1 (fr) Compositions destinees a reduire les inflammations et a abaisser le cholesterol sanguin
CN1208351A (zh) 含薯蓣皂苷配基的组合物
WO1999020291A3 (fr) Gingko biloba de qualite pharmaceutique
JP7545683B2 (ja) エンテロコッカス・フェカーリス、その培養液またはその死菌体を有効成分として含有する筋肉の減退、低下及び筋萎縮の予防、改善または治療用の薬学組成物、食品組成物及び食品添加剤
BRPI0413714A (pt) frações de leite e preparações de leite para tratamento e/ou prevenção de doenças mediadas por cox-2
WO2000078724A3 (fr) Composes pharmaceutiques
Sharma et al. Indigenous therapeutics of Alzheimer: A review of ayurvedic herbs from its ethnobotany to phytotherapy
WO2003022218A3 (fr) Composes et compositions de nitroxyde a protection carboxylate (cgn), et methodes d'utilisation
EP3189837B1 (fr) Utilisations d'un composé flavonoïde dans la préparation d'une composition cicatrisante
RU2145228C1 (ru) Профилактическое и общеукрепляющее средство широкого спектра действия
JP2004137218A (ja) 脂肪分解促進剤ならびにそれを用いた皮膚外用剤および飲食物

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP